HTA9 The Benefits That a Novel Antimicrobial Provides When Viewed From an Insurance Value Perspective
Abstract
Authors
MS Chan R Holloway R King R Polya R Sloan JC Kowalik T Ashfield LS Moore T Porter J Pearson-Stuttard
MS Chan R Holloway R King R Polya R Sloan JC Kowalik T Ashfield LS Moore T Porter J Pearson-Stuttard
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now